Even though ADNI2GO did not reach statistical significance, it had a similar beta coefficients and direction, possibly due to the low proportion of AD cases in this cohort (6.55%).
← all excerpts
Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO.
1
—
—